C12Y 301/0405
Glycosylphosphatidylinositol phospholipase d
Official title: Glycosylphosphatidylinositol phospholipase D (3.1.4.50)
C12Y301/0405 (Glycosylphosphatidylinositol phospholipase d) appears on 0 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 4
- Assignees
- 2
- Inventors
- 6
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Exercise-induced circulatory factors for amelioration of cognitive, neurological, and regenerative dysfunction during aging21 Apr 2022US 2022/0118060 A1The Regents of the University of California
- Glycosyl phosphatidyl inositol specific phospholipase D proteins and uses thereof30 Nov 2006US 2006/0269537 A1Sylus Pharmaceutical Ltd.
- Materials and methods relating for the treatment and diagnosis of pre-eclampsia26 Aug 2004US 2004/0167064 A1
- Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis10 Jun 2004US 2004/0110263 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.